About
Kaiser Bio provides in vivo and in vitro efficacy evaluation services for new drug candidates, focusing on neurodegenerative diseases such as dementia, and offers customized consulting for pharmaceutical and biotech companies.
Explore Kaiser Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.